Jeremy Grantham Johnson & Johnson Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$27.2 Billion
Q1 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Johnson & Johnson stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 4,827,532 shares of JNJ stock, worth $747 Million. This represents 2.8% of its overall portfolio holdings.

Number of Shares

4,827,532

Previous 3,986,364 21.1%

Holding current value

$747 Million

Previous $625 Million 22.22%

% of portfolio

2.8%

Previous 2.78%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $131 Million - $137 Million	841,168 Added 21.1%	4,827,532 $764 Million
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $35.2 Million - $38.4 Million	241,507 Added 6.45%	3,986,364 $625 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $59.5 Million - $66.7 Million	382,035 Added 11.36%	3,744,857 $583 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $56 Million - $60.3 Million	362,803 Added 12.09%	3,362,822 $557 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $9.87 Million - $11.8 Million	65,324 Added 2.23%	3,000,019 $465 Million

Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $10.9 Million - $12.2 Million	-67,804 Reduced 2.26%	2,934,695 $518 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $118 Million - $131 Million	728,785 Added 32.05%	3,002,499 $490 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $51.5 Million - $57 Million	-306,216 Reduced 11.87%	2,273,714 $404 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $3.84 Million - $4.36 Million	24,261 Added 0.95%	2,579,930 $457 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $5.44 Million - $6.04 Million	34,890 Added 1.38%	2,555,669 $437 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $19.9 Million - $22.1 Million	123,148 Added 5.14%	2,520,779 $407 Million
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $8.36 Million - $8.97 Million	52,426 Added 2.24%	2,397,631 $395 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $1.75 Million - $1.95 Million	11,452 Added 0.49%	2,345,205 $385 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $3.42 Million - $3.92 Million	-24,932 Reduced 1.06%	2,333,753 $367 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $11.9 Million - $13 Million	84,414 Added 3.71%	2,358,685 $351 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $6.77 Million - $8.18 Million	-52,586 Reduced 2.26%	2,274,271 $320 Million
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $35.4 Million - $49.1 Million	-318,681 Reduced 12.05%	2,326,857 $305 Million
Q4 2019 Feb 13, 2020	BUY	$127.5 - $146.44 $53.8 Million - $61.7 Million	421,607 Added 18.96%	2,645,538 $386 Million
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $8.32 Million - $9.32 Million	65,566 Added 3.04%	2,223,931 $288 Million
Q2 2019 Aug 13, 2019	SELL	$131.15 - $144.24 $14.2 Million - $15.7 Million	-108,590 Reduced 4.79%	2,158,365 $301 Million
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $22.6 Million - $25.1 Million	-179,454 Reduced 7.34%	2,266,955 $317 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $23.1 Million - $27.8 Million	-188,034 Reduced 7.14%	2,446,409 $316 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $121 Million - $142 Million	-993,046 Reduced 27.38%	2,634,443 $364 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $157 Million - $173 Million	-1,314,314 Reduced 26.6%	3,627,489 $440 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $77.9 Million - $92.2 Million	622,584 Added 14.41%	4,941,803 $633 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $32.2 Million - $35.3 Million	-245,619 Reduced 5.38%	4,319,219 $603 Million
Q3 2017 Nov 14, 2017	SELL	$129.47 - $135.38 $62.8 Million - $65.7 Million	-485,071 Reduced 9.61%	4,564,838 $593 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,049,909	5,049,909 $668 Million

Others Institutions Holding JNJ

# of Institutions

4,139

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account